Loading organizations...
NuVasive designs and manufactures medical devices and provides procedural solutions primarily for spine surgery. The company develops technologies that facilitate minimally invasive approaches, including advanced neuromonitoring, surgical navigation, and specialized instrumentation. Its offerings aim to enhance surgical precision and optimize patient recovery in spinal procedures.
NuVasive was founded in 1997 by Dr. Jim Marino. Dr. Marino's foundational insight stemmed from his experience with arthroscopic surgery's minimally invasive successes, contrasting sharply with the highly invasive nature of traditional spine procedures. He recognized the critical need for new technologies in patient-independent nerve monitoring, precise navigation, and cannula-mediated surgical intervention to bring similar benefits to spine care.
The company's products serve hospitals and spine surgeons, ultimately benefiting patients by enabling less invasive surgical options. NuVasive's vision centers on continuously advancing spine surgery through innovation, developing comprehensive procedural solutions that improve clinical outcomes and address unmet needs in the global spine market.
Key people at NuVasive.
NuVasive has 1 tracked investment across 1 company. The latest tracked deal is $2.6M Series A in FYR Medical in February 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 14, 2023 | FYR Medical | $2.6M Series A | Nuvasive | — |
Key people at NuVasive.